You have 9 free searches left this month | for more free features.

ocular graft-versus-host disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Graft-versus-host-disease, Ocular Graft-versus-host Disease Trial in Bellaire (Lifitegrast 5% Ophthalmic Solution, Refresh)

Not yet recruiting
  • Graft-versus-host-disease
  • Ocular Graft-versus-host Disease
  • Lifitegrast 5% Ophthalmic Solution
  • Refresh
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Apr 27, 2022

Ocular Graft-versus-host Disease Trial in Saint Louis (Vigamox, Placebo)

Recruiting
  • Ocular Graft-versus-host Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 12, 2022

Ocular Graft-versus-host Disease Trial in Saint-Petersburg (Allogeneic platelet lysate eye drops)

Recruiting
  • Ocular Graft-versus-host Disease
  • Allogeneic platelet lysate eye drops
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 4, 2022

Ocular Graft-versus-host Disease Trial in Needham (Pro-ocular™ Topical Gel 1%, Placebo)

Recruiting
  • Ocular Graft-versus-host Disease
  • Pro-ocular™ Topical Gel 1%
  • Placebo
  • Needham, Massachusetts
    BostonSight
Dec 1, 2021

GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)

Completed
  • Graft Versus Host Disease in Eye
  • Beijing, Beijing, China
    Peking University Third Hospital
Mar 14, 2022

Graft Vs Host Disease, Haematological Malignancy, Cancer Trial in Hong Kong

Recruiting
  • Graft Vs Host Disease
  • +2 more
    • Hong Kong, Hong Kong
      Department of Ophthalmology, LKS Faculty of Medicine, The Univer
    Dec 9, 2021

    Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients

    Recruiting
    • Ocular GVHD
      • Indianapolis, Indiana
        Glick Eye Institute - Indiana University
      Sep 2, 2021

      Ocular Surface Disease in Chronic Graft-Versus-Host Disease

      Recruiting
      • Dry Eye
      • GVHD
      • Cross-sectional study
      • Singapore, Singapore
        Cynthia Boo
      Mar 22, 2022

      Chronic Ocular Graft-versus-host Disease Trial in Boston (Pro-ocular™ topical gel, Placebo topical gel)

      Active, not recruiting
      • Chronic Ocular Graft-versus-host Disease
      • Pro-ocular™ topical gel
      • Placebo topical gel
      • Boston, Massachusetts
        Massachusetts Eye and Ear Longwood
      Mar 12, 2021

      Ocular GVHD Trial in Salt Lake City (Amniotic Fluid Eye Drops (AFED), Saline Solution)

      Recruiting
      • Ocular Graft Versus Host Disease
      • Amniotic Fluid Eye Drops (AFED)
      • Saline Solution
      • Salt Lake City, Utah
        University of Utah Huntsman Cancer Institute
      Feb 3, 2021

      Graft-versus-host-disease, CMV Trial (Letermovir)

      Not yet recruiting
      • Graft-versus-host-disease
      • CMV
      • (no location specified)
      Jul 23, 2023

      Dry Eye, Graft-versus-host-disease, Ocular Discomfort Trial in United States (CAM-101 10%, Vehicle Control, CAM-101 30%)

      Completed
      • Dry Eye
      • +2 more
      • CAM-101 10%
      • +2 more
      • Palo Alto, California
      • +5 more
      Jul 26, 2021

      Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

      Not yet recruiting
      • Steroid-refractory Acute Graft-versus-host Disease
      • MC0518
      • BAT
      • (no location specified)
      Oct 4, 2023

      Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

      Not yet recruiting
      • Acute Graft Versus Host Disease
      • Hematopoietic and Lymphoid System Neoplasm
      • Fecal Microbiota Transplantation Capsule
      • Placebo
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 6, 2023

      Patients at Risk for Chronic Graft-Versus-Host Disease

      Not yet recruiting
      • cGVHD
      • Non-Interventional
      • (no location specified)
      Jun 16, 2023

      Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular

      Withdrawn
      • Graft Vs Host Disease
      • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
      • Regular dissolvable intracanalicular plug
      • Boston, Massachusetts
        Mass Eye and Ear
      Dec 14, 2021

      Chronic GVHD Trial in United States (drug, procedure, other)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • Tampa, Florida
      • +4 more
      Aug 10, 2023

      Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

      Not yet recruiting
      • Graft Vs Host Disease
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 18, 2023

      Acute GVHD Trial (Itolizumab, Methylprednisolone)

      Not yet recruiting
      • Acute Graft Versus Host Disease
      • (no location specified)
      Apr 10, 2023

      A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

      Not yet recruiting
      • Graft-versus-Host Disease
      • ruxolitinib
      • (no location specified)
      Jan 11, 2023

      Intestinal GVHD Trial in Seattle (procedure, biological, dietary supplement, other)

      Not yet recruiting
      • Intestinal Graft Versus Host Disease
      • Colonoscopy
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 25, 2023

      Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

      Recruiting
      • Chronic Graft-Versus-Host Disease
      • Allogeneic Stem Cell Transplant
      • App
      • Usual Care
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Jan 24, 2023

      Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

      Recruiting
      • Acute Graft Versus Host Disease
      • Hematopoietic and Lymphoid System Neoplasm
      • Duarte, California
        City of Hope Medical Center
      Jan 5, 2023

      GVHD Trial in Tampa (Cultured Treg cells)

      Completed
      • Graft Versus Host Disease
      • Cultured Treg cells
      • Tampa, Florida
        H Lee Moffitt Cancer Center
      Nov 2, 2022

      Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • Atlanta, Georgia
        Northside Hospital
      Sep 21, 2023